Beverly Hills spine surgeons complete three-level cervical disc replacement following recent FDA approval of motion-preserving technology BEVERLY HILLS, CA /...
Powered by BergacynFF®, the only patented botanical blend clinically demonstrated to reduce liver fat accumulation and support healthy body weight...
April 8, 2026 Company Announcement No. 7 BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC...
As President Trump Directs Acting Attorney General Todd Blanche to Fast-Track Marijuana Rescheduling, MMJ International Holdings Emphasizes the Necessity of...
Expansion supports accelerated enrollment and advancement of the Company’s lead clinical assetNEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence...
Expansion supports accelerated enrollment and advancement of the Company’s lead clinical assetNEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence...
Joshua Hare Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron The patent relates to potency...
Joshua Hare Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron The patent relates to potency...
Mesoblast outlines commercial strategy to double net revenues as Ryoncil® approaches US$100M net revenue milestone since launch last year Showcases...
Mesoblast outlines commercial strategy to double net revenues as Ryoncil® approaches US$100M net revenue milestone since launch last year Showcases...
Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial potential Statistical...
Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial potential Statistical...
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic TreatmentCOLUMBIA, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose...
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic TreatmentCOLUMBIA, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose...
Patent Expands Protection for the Company’s RenovoCath Device, the Novel Dual-Occlusion Catheter-Based System RenovoRx Currently Holds a Strong and Growing...
Patent Expands Protection for the Company’s RenovoCath Device, the Novel Dual-Occlusion Catheter-Based System RenovoRx Currently Holds a Strong and Growing...
- Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to...
SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is...
Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended...
DUBLIN and BRIDGEWATER, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to...